Randomized, three- way, three- period, single oral dose, open-label, crossover, bioequivalence study to compare Lorvast Tablets /Tabuk Pharmaceutical Mfg. Co. (20 mg Atorvastatin), versus Lipitor® (20 mg Atorvastatin) Produced by Pfizer in healthy subjects under fasting conditions.
2020-07-04
عنوان الدراسة
Randomized, three- way, three- period, single oral dose, open-label, crossover, bioequivalence study to compare Lorvast Tablets /Tabuk Pharmaceutical Mfg. Co. (20 mg Atorvastatin), versus Lipitor® (20 mg Atorvastatin) Produced by Pfizer in healthy subjects under fasting conditions.
داعم الدراسة
SFDA
دواء الدراسة
Lipitor® lovarst tablet
رقم بروتوكول الدراسة
42370
حالة الدراسة
Completed
موقع الدراسة
saudi Ajal
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。